Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Adhesion molecules and arginase enzyme: Promising therapeutic targets for human ulcerative colitis

3rd International Conference on Clinical Pharmacy

Abdul-Aziz Elshemary

Riyadh Military Hospital, Saudi Arabia

ScientificTracks Abstracts: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X.C1.016

Abstract
Background & Aim of the work: Ulcerative Colitis (UC) is a chronic Inflammatory Bowel Disease (IBD). The hallmark of UC lesions is infiltration of the intestine by mononuclear cells, predominantly lymphocytes. This cellular infiltration is the result of increased leukocyte recruitment and proliferation in the inflamed colon. Adhesion molecules are cell surface-expressed glycoproteins that mediate cell-cell and cell-extracellular matrix interactions. They play a prominent role in leukocyte recruitment. Adhesion molecules, therefore, represent promising therapeutic targets for human inflammatory diseases, including UC. The arginase (AR) has gained attention in studies focusing on the pathophysiology of IBD. The aim of the present descriptive study is to investigate the serum level of the adhesion molecules (ICAM and E-selectin) and arginase enzyme of patients diagnosed with UC in central hospital, Arar, Saudi Arabia to illustrate the magnitude of UC problem in northern border region of Saudi Arabia and to confirm the role of adhesion molecules and arginase in pathogenesis of UC in these patients. Methodology: The study is a retrospective study of 24 cases of UC diagnosed and followed up in central hospital in Arar, Saudi Arabia, from January 2015 to July 2015. Samples of blood were taken from the diagnosed cases for measurement of serum levels of ICAM, E-Selectin and arginase enzyme by Enzyme-Linked Immunosorbent Assay (ELISA) in addition to C-Reactive Protein (CRP). Results: Compared to control groups formed by individuals without clinical and/or laboratory signs of UC, UC patients showed significant increased levels (p<0.001) of sICAM-1, E-selectin and CRP in serum samples. On the other hand, arginase serum levels decreased significantly in sera of UC patients. Conclusion: In conclusion, the present work confirmed the role of adhesion molecules notably ICAM and E-selectin and the acute phase biomarker CRP in pathogenesis of UC and suggested a protective effect of arginase enzyme in reducing inflammation in colitis. Anti-adhesion molecules targeting ICAM and E-selectin may be promising for treatment of UC.
Biography

Abdul-Aziz Elshemary has completed his MBBcH from Northern borders University, Saudi Arabia. He is now working as a Resident Physician at Military Hospital in Riyadh, KSA. He is working on elaborating many researches for publishing with his staff members in the University.

Email: azizmn123@gmail.com

Top